KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Shares Issued (2016 - 2025)

Pacific Biosciences Of California (PACB) has 16 years of Shares Issued data on record, last reported at $1.5 million in Q3 2025.

  • For Q3 2025, Shares Issued rose 80.91% year-over-year to $1.5 million; the TTM value through Dec 2025 reached $3.4 million, down 55.5%, while the annual FY2025 figure was $3.4 million, 55.5% down from the prior year.
  • Shares Issued reached $1.5 million in Q3 2025 per PACB's latest filing, down from $2.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $182.0 million in Q2 2023 and bottomed at -$6.4 million in Q3 2022.
  • Average Shares Issued over 5 years is $17.4 million, with a median of $3.9 million recorded in 2021.
  • Peak YoY movement for Shares Issued: tumbled 233.89% in 2022, then skyrocketed 21358.14% in 2023.
  • A 5-year view of Shares Issued shows it stood at $1.7 million in 2021, then soared by 566.47% to $11.2 million in 2022, then soared by 1520.35% to $182.0 million in 2023, then plummeted by 99.55% to $812000.0 in 2024, then surged by 80.91% to $1.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $1.5 million in Q3 2025, $2.0 million in Q1 2025, and $812000.0 in Q3 2024.